Senti Biosciences Holdings (SNTI) Earnings Date & Reports

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SNTI is expected to report earnings to fall 28.05% to -29 cents per share on November 12

Senti Biosciences Holdings SNTI Stock Earnings Reports

Q3'26

Est.

$-0.29

Q2'26

Missed

by $0.10

Q1'26

Beat

by $0.28

Q4'25

Missed

by $0.12

Q3'25

Missed

by $0.14

The last earnings report on August 31 showed earnings per share of -40 cents, missing the estimate of -31 cents. With 70.46K shares outstanding, the current market capitalization sits at 9.53M.

View a ticker or compare two or three

SNTI

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for SNTI